| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
23.6 |
% |
10.6019/CHEMBL4513141 |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Candida albicans |
Candida albicans |
Inhibition |
2.18 |
% |
10.6019/CHEMBL4513141 |
| Canis lupus familiaris |
Canis familiaris |
ED50 |
15.0 |
mg.kg-1 |
10.1021/jm400820m |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-8.15 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
Inhibition |
-0.51 |
% |
10.6019/CHEMBL4513141 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Acyl coenzyme A:cholesterol acyltransferase |
Drug metabolism |
85.0 |
% |
10.1016/j.bmcl.2022.128969 |
| Homo sapiens |
Acyl coenzyme A:cholesterol acyltransferase |
Drug metabolism |
85.0 |
% |
10.1016/j.ejmech.2017.02.011 |
| Homo sapiens |
Acyl coenzyme A:cholesterol acyltransferase |
Km |
55700.0 |
nM |
10.1016/j.bmc.2009.10.052 |
| Homo sapiens |
Acyl coenzyme A:cholesterol acyltransferase |
pKm |
4.25 |
None |
10.1016/j.bmc.2009.10.052 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bile salt export pump |
AC50 |
40000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Blood |
Drug metabolism |
25.0 |
% |
10.1021/acs.jmedchem.7b00510 |
| Homo sapiens |
Bradykinin B1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
89125.1 |
nM |
None |
| Homo sapiens |
Corticotropin releasing factor receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Drug metabolism |
nan |
None |
10.1021/ml3002067 |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2B6 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2B6 |
Drug metabolism |
nan |
None |
10.1021/ml3002067 |
| Homo sapiens |
Cytochrome P450 2B6 |
Inhibition |
44.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 2B6 |
Ki |
500.0 |
nM |
10.1021/jm300065h |
| Homo sapiens |
Cytochrome P450 2B6 |
Ki |
500.0 |
nM |
10.2174/138920005774330639 |
| Homo sapiens |
Cytochrome P450 2B6 |
Ki |
1100.0 |
nM |
10.2174/138920005774330639 |
| Homo sapiens |
Cytochrome P450 2B6 |
Kinact |
0.15 |
min-1 |
10.2174/138920005774330639 |
| Homo sapiens |
Cytochrome P450 2B6 |
Kinact |
0.35 |
/min |
10.1021/jm300065h |
| Homo sapiens |
Cytochrome P450 2B6 |
Kinact |
0.35 |
min-1 |
10.2174/138920005774330639 |
| Homo sapiens |
Cytochrome P450 2C19 |
Drug metabolism |
nan |
None |
10.1021/ml3002067 |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
14300.0 |
nM |
10.1021/jm300065h |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Kinact |
0.055 |
/min |
10.1021/jm300065h |
| Homo sapiens |
Cytochrome P450 2C19 |
mechanism based inhibition |
nan |
None |
10.2174/138920005774330639 |
| Homo sapiens |
Cytochrome P450 2C8 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 2C9 |
Drug metabolism |
nan |
None |
10.1021/ml3002067 |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Drug metabolism |
nan |
None |
10.1021/ml3002067 |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Inhibition |
35.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4/3A5 |
Drug metabolism |
nan |
None |
10.1021/ml3002067 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
18999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D5 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-B |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gastric inhibitory polypeptide receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
HERG |
AC50 |
26089.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-51.79 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
0.38 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
Activity |
52.0 |
% |
10.1021/jm300065h |
| Homo sapiens |
Homo sapiens |
Activity |
60.0 |
% |
10.1021/jm300065h |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
7.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
Drug metabolism |
15.0 |
% |
10.1021/acs.jmedchem.7b00510 |
| Homo sapiens |
Homo sapiens |
Drug metabolism |
70.0 |
% |
10.1021/acs.jmedchem.7b00510 |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
14895.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
Liver microsome |
CL |
0.000236 |
mL.min-1.g-1 |
10.1124/dmd.111.039180 |
| Homo sapiens |
Liver microsome |
Drug metabolism |
23.6 |
pmol/min |
10.1124/dmd.111.039180 |
| Homo sapiens |
Liver microsome |
PB |
417.4 |
pmol |
10.1124/dmd.111.039180 |
| Homo sapiens |
Liver microsomes |
CL |
300.0 |
mL.min-1.g-1 |
10.1016/j.bmcl.2011.12.005 |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
12999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
26999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Parathyroid hormone receptor |
Potency |
89125.1 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 6A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Pregnane X receptor |
AC50 |
15693.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Purinergic receptor P2Y12 |
IC50 |
2400.0 |
nM |
10.1016/j.bmcl.2022.128837 |
| Homo sapiens |
Purinergic receptor P2Y12 |
Inhibition |
nan |
% |
10.1016/j.ejmech.2017.11.014 |
| Homo sapiens |
Rap guanine nucleotide exchange factor 4 |
Potency |
79432.8 |
nM |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
16000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
2000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 5a (5-HT5a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 7 (5-HT7) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
562.0 |
nM |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
299.0 |
nM |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Influenza A virus |
Nonstructural protein 1 |
Potency |
19952.6 |
nM |
None |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
14.99 |
% |
10.6019/CHEMBL4513141 |
| Macaca fascicularis |
Cynomolgus monkey |
Activity |
48.0 |
% |
10.1016/j.ejmech.2020.112893 |
| Macaca fascicularis |
Cynomolgus monkey |
Activity |
100.0 |
% |
10.1021/acs.jmedchem.2c00359 |
| Macaca fascicularis |
Cynomolgus monkey |
Activity |
nan |
None |
10.1021/acs.jmedchem.2c00359 |
| Macaca fascicularis |
Cynomolgus monkey |
FC |
7.3 |
None |
10.1016/j.ejmech.2020.112893 |
| Macaca fascicularis |
Cynomolgus monkey |
FC |
8.1 |
None |
10.1016/j.ejmech.2020.112893 |
| Macaca fascicularis |
Cynomolgus monkey |
FC |
10.0 |
None |
10.1016/j.ejmech.2020.112893 |
| Mus musculus |
Mus musculus |
Activity |
50.0 |
% |
10.1016/j.ejmech.2016.01.019 |
| Mus musculus |
Mus musculus |
Activity |
60.0 |
% |
10.1016/j.ejmech.2014.05.017 |
| Mus musculus |
Mus musculus |
Activity |
70.0 |
% |
10.1016/j.ejmech.2016.01.019 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1016/j.ejmech.2014.05.017 |
| Mus musculus |
Mus musculus |
FC |
2.3 |
None |
10.1016/j.ejmech.2014.05.017 |
| Mus musculus |
Mus musculus |
TIME |
0.15 |
hr |
10.1016/j.ejmech.2016.01.019 |
| Mus musculus |
Mus musculus |
TIME |
0.3833 |
hr |
10.1016/j.ejmech.2016.01.019 |
| Mus musculus |
Mus musculus |
TIME |
6.0 |
hr |
10.1021/acs.jmedchem.6b01360 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
FC |
6.0 |
None |
10.1021/jm5006226 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Inhibition |
nan |
% |
10.1021/jm5006226 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
8275.3 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
11689.1 |
nM |
None |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
15.58 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
5100.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
27700.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Liver microsomes |
Drug metabolism |
nan |
None |
10.1021/jm300038c |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.077 |
g |
10.1016/j.ejmech.2019.111722 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.253 |
g |
10.1016/j.ejmech.2019.111722 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.44 |
g |
10.1021/acs.jmedchem.8b01971 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.7 |
g |
10.1021/acs.jmedchem.8b01971 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
1.2 |
g |
10.1021/acs.jmedchem.8b01971 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
1.99 |
g |
10.1021/acs.jmedchem.8b01971 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
46.1 |
% |
10.1016/j.ejmech.2019.111722 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
57.0 |
% |
10.1021/acs.jmedchem.8b01971 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
67.0 |
% |
10.1016/j.bmcl.2014.01.066 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
67.0 |
% |
10.1021/jm4013906 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
38000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
39700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
41000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
42000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
362.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
399.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
406.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
463.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
62.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
76.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
84.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
98.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
90.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
110.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
113.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
160.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AUC |
32200.0 |
ng.hr.mL-1 |
10.1021/jm300038c |
| Rattus norvegicus |
Rattus norvegicus |
BASO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
136.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
160.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
163.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
170.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
101.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
102.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
102.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
103.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
646.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
723.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
800.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
866.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
230.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
460.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
941.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
1432.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Cmax |
21.53 |
nM |
10.1021/jm300038c |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
25000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
26000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
27000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
27670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.5 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.1 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.2 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ED100 |
2.36 |
mg kg-1 |
10.1021/acs.jmedchem.8b01971 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
2.6 |
mg.kg-1 |
10.1021/jm500588w |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
4.13 |
mg.kg-1 |
10.1016/j.bmcl.2022.128969 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
7.0 |
mg.kg-1 |
10.1021/acs.jmedchem.8b01971 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
11.85 |
mg.kg-1 |
10.1016/j.bmcl.2022.128969 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
86.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
102.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
114.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
131.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
1.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
FC |
6.2 |
None |
10.1016/j.bmcl.2014.01.066 |
| Rattus norvegicus |
Rattus norvegicus |
FC |
8.2 |
None |
10.1016/j.bmcl.2014.01.066 |
| Rattus norvegicus |
Rattus norvegicus |
FC |
8.2 |
None |
10.1021/jm4013906 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1350.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1450.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1666.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
2143.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
27.97 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
31.5 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
31.7 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
32.5 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
114300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
126000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
128000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
131300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
26.5 |
% |
10.1016/j.bmcl.2022.128969 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
41.5 |
% |
10.1016/j.bmcl.2022.128969 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
59.7 |
% |
10.1016/j.bmcl.2022.128969 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
72.6 |
% |
10.1016/j.bmcl.2022.128969 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
90.5 |
% |
10.1016/j.bmcl.2022.128969 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
nan |
% |
10.1016/j.bmcl.2022.128969 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
134.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
361.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
416.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
452.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
9.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
10.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
12.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
14.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
7690.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
12550.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
12643.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
15650.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
84.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
88.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
92.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
93.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.17 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.5 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
25.37 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
26.23 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
400000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
404000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
409000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
60.37 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
60.77 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.8 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
64.13 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
49.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
229.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
297.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
4.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
7.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
9.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
13.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
312.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1021.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1366.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
2887.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
105.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
125.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
127.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
130.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
209670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
995330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1167670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1169330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.63 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.99 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.16 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.34 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
54000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
54700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
56000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
56700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
4360000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5170000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5210000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5220000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.0 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.33 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
141.23 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
141.87 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
143.27 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
143.43 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
T1/2 |
2.48 |
hr |
10.1021/jm300038c |
| Rattus norvegicus |
Rattus norvegicus |
TIME |
0.675 |
hr |
10.1021/acs.jmedchem.8b01971 |
| Rattus norvegicus |
Rattus norvegicus |
Tissue Severity Score |
nan |
None |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Tmax |
0.583 |
hr |
10.1021/jm300038c |
| Rattus norvegicus |
Rattus norvegicus |
TT |
21.0 |
min |
10.1016/j.ejmech.2019.111722 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
11.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
11.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
18.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
20.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
8170.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
13770.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
14230.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
18970.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated N-type calcium channel alpha-1B subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
17.95 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.07177 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.03 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.9279 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
FICI |
0.19 |
None |
10.1016/j.bmcl.2013.12.069 |
| Staphylococcus aureus |
Staphylococcus aureus |
FICI |
8.1 |
None |
10.1016/j.bmcl.2013.12.069 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
12.7 |
% |
10.6019/CHEMBL4513141 |
| None |
ADMET |
CL |
0.000848 |
mL.min-1.g-1 |
10.1124/dmd.111.039180 |
| None |
ADMET |
CL |
1.084 |
uL/min |
10.1124/dmd.111.039180 |
| None |
ADMET |
CL |
137.0 |
uL.min-1.(10^6cells)-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
CL |
150.0 |
mL.min-1.g-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
Drug metabolism |
70.0 |
% |
10.1021/acs.jmedchem.9b00917 |
| None |
ADMET |
Drug metabolism |
nan |
None |
10.1021/ml3002067 |
| None |
ADMET |
IC50 |
50.0 |
nM |
10.1124/dmd.111.042416 |
| None |
ADMET |
IC50 |
140.0 |
nM |
10.1124/dmd.111.042416 |
| None |
ADMET |
PPB |
2.0 |
% |
10.1021/acs.jmedchem.9b00917 |
| None |
ADMET |
PPB |
98.64 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
Stability |
94.0 |
% |
10.1016/j.bmcl.2022.128969 |
| None |
ADMET |
Stability |
96.0 |
% |
10.1016/j.bmcl.2022.128969 |
| None |
ADMET |
Stability |
100.0 |
% |
10.1016/j.bmcl.2022.128969 |
| None |
ADMET |
Stability |
101.0 |
% |
10.1016/j.bmcl.2022.128969 |
| None |
ADMET |
Stability |
102.0 |
% |
10.1016/j.bmcl.2022.128969 |
| None |
ADMET |
Stability |
104.0 |
% |
10.1016/j.bmcl.2022.128969 |
| None |
ADMET |
Stability |
106.0 |
% |
10.1016/j.bmcl.2022.128969 |
| None |
ADMET |
TI |
2.3 |
None |
10.1021/jm400820m |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
4.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
NON-PROTEIN TARGET |
Activity |
93.3 |
% |
10.1016/j.bmcl.2016.11.046 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1021/acs.jmedchem.6b01360 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
3.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
7600.0 |
nM |
10.1039/C4MD00022F |
| None |
NON-PROTEIN TARGET |
Inhibition |
3.5 |
% |
10.1016/j.bmc.2011.08.004 |
| None |
NON-PROTEIN TARGET |
Inhibition |
77.6 |
% |
10.1039/C4MD00022F |
| None |
NON-PROTEIN TARGET |
Inhibition |
80.2 |
% |
10.1021/np400772h |
| None |
NON-PROTEIN TARGET |
Inhibition |
85.2 |
% |
10.1016/j.bmc.2011.08.004 |
| None |
NON-PROTEIN TARGET |
Inhibition |
86.9 |
% |
10.1039/C4MD00022F |
| None |
NON-PROTEIN TARGET |
Inhibition |
92.3 |
% |
10.1039/C4MD00022F |
| None |
NON-PROTEIN TARGET |
Inhibition |
94.5 |
% |
10.1039/C4MD00022F |
| None |
No relevant target |
LogD7.4 |
3.69 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
LogP |
3.74 |
None |
10.1016/j.ejmech.2021.113924 |
| None |
Platelet |
Inhibition |
nan |
% |
10.1016/j.ejmech.2018.05.008 |
| None |
Unchecked |
Hepatotoxicity (acute) |
5.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
4.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
150000.0 |
nM |
10.1016/j.bmcl.2013.12.069 |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Ki |
nan |
None |
None |